down arrow

Ishita Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE806D01016
  • NSEID:
  • BSEID: 524400
INR
82.20
-0.5 (-0.6%)
BSENSE

Apr 11, 12:30 PM

BSE+NSE Vol: 170

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

81.0282.40

52 Week

56.00104.75
Valuation
Technical
Day's Volume

CASH

170 (-15.42%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

49.84%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 8.34%

  • Poor long term growth as Net Sales has grown by an annual rate of 0.73% and Operating profit at 7.86% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.79
2

Flat results in Dec 24

 
3

Stock is technically in a Mildly Bearish range

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 24 Cr (Micro Cap)

stock-summary
P/E

25.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.79

stock-summary
Return on Equity

8.67%

stock-summary
Price to Book

2.49

Revenue and Profits (1 Year):
Net Sales:
4 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
2.75%
0%
2.75%
1 Year
15.14%
0%
15.14%
2 Years
64.4%
0%
64.4%
3 Years
82.26%
0%
82.26%
4 Years
165.16%
0%
165.16%
5 Years
689.63%
0%
689.63%

Ishita Drugs for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0.73%
EBIT Growth (5y)
7.86%
EBIT to Interest (avg)
0.79
Debt to EBITDA (avg)
0.68
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.62
Tax Ratio
24.35%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
38.53%
ROE (avg)
8.34%
Valuation key factors
Factor
Value
P/E Ratio
25
Industry P/E
33
Price to Book Value
2.49
EV to EBIT
16.85
EV to EBITDA
16.52
EV to Capital Employed
8.26
EV to Sales
1.13
PEG Ratio
0.77
Dividend Yield
NA
ROCE (Latest)
39.71%
ROE (Latest)
8.67%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Umang Financial Services Limited (9.94%)

Highest Public shareholder

Mahendra Girdharilal Wadhwani (1.98%)

Individual Investors Holdings

46.89%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 26.30% vs 7.92% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 26.32% vs 26.67% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.13",
          "val2": "3.27",
          "chgp": "26.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.30",
          "val2": "0.24",
          "chgp": "25.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.02",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.24",
          "val2": "0.19",
          "chgp": "26.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.26%",
          "val2": "7.34%",
          "chgp": "-0.08%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -15.78% vs 20.84% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -2.86% vs 25.00% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6.30",
          "val2": "7.48",
          "chgp": "-15.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.42",
          "val2": "0.39",
          "chgp": "7.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "0.03",
          "chgp": "-66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.34",
          "val2": "0.35",
          "chgp": "-2.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.67%",
          "val2": "5.21%",
          "chgp": "1.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -2.43% vs 13.12% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 23.40% vs 17.50% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10.43",
          "val2": "10.69",
          "chgp": "-2.43%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.72",
          "val2": "0.61",
          "chgp": "18.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.03",
          "val2": "0.07",
          "chgp": "-57.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.58",
          "val2": "0.47",
          "chgp": "23.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.90%",
          "val2": "5.71%",
          "chgp": "1.19%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 25.85% vs -14.34% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 29.31% vs -28.40% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "15.19",
          "val2": "12.07",
          "chgp": "25.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.91",
          "val2": "0.76",
          "chgp": "19.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.09",
          "val2": "0.05",
          "chgp": "80.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.75",
          "val2": "0.58",
          "chgp": "29.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.99%",
          "val2": "6.30%",
          "chgp": "-0.31%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
4.13
3.27
26.30%
Operating Profit (PBDIT) excl Other Income
0.30
0.24
25.00%
Interest
0.02
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.24
0.19
26.32%
Operating Profit Margin (Excl OI)
7.26%
7.34%
-0.08%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 26.30% vs 7.92% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 26.32% vs 26.67% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
6.30
7.48
-15.78%
Operating Profit (PBDIT) excl Other Income
0.42
0.39
7.69%
Interest
0.01
0.03
-66.67%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.34
0.35
-2.86%
Operating Profit Margin (Excl OI)
6.67%
5.21%
1.46%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -15.78% vs 20.84% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -2.86% vs 25.00% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
10.43
10.69
-2.43%
Operating Profit (PBDIT) excl Other Income
0.72
0.61
18.03%
Interest
0.03
0.07
-57.14%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.58
0.47
23.40%
Operating Profit Margin (Excl OI)
6.90%
5.71%
1.19%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -2.43% vs 13.12% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 23.40% vs 17.50% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
15.19
12.07
25.85%
Operating Profit (PBDIT) excl Other Income
0.91
0.76
19.74%
Interest
0.09
0.05
80.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.75
0.58
29.31%
Operating Profit Margin (Excl OI)
5.99%
6.30%
-0.31%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 25.85% vs -14.34% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 29.31% vs -28.40% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Ishita Drugs & Industries Ltd stock-summary
stock-summary
Ishita Drugs & Industries Ltd
Micro Cap
Pharmaceuticals & Drugs
Ishita Drugs & Industries Limited was incorporated in Feb.'92 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient. It has a state-of-art manufacturing facility, in terms of reaction capabilities, quality control and environmental safety. The plant has been designed and constructed to meet GMP norms. The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr.
Company Coordinates stock-summary
Company Details
Survey No 179/1 Taluka Sanand, Village Vasna-Iyava Ahmedabad Gujarat : 382170
stock-summary
Tel:
stock-summary
http://www.ishitadrugs.com
stock-summary
ishitadrugs@vsnl.net
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."